4574.T Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 08:15):

Stats
Tagesvolumen	99 000.00
Durchschnittsvolumen	488 822
Marktkapitalisierung	17.40B
EPS	¥0 ( 2024-02-08 )
Nächstes Ertragsdatum	( ¥0 ) 2024-05-09
Last Dividend	¥13.00 ( 2021-12-29 )
Next Dividend	¥0 ( N/A )
P/E	-4.55
ATR14	¥0.925 (0.27%)

Volumen Korrelation

Lang: -0.05 (neutral)

Kurz: 0.00 (neutral)

Signal:(57.935) Neutral

Taiko Pharmaceutical Korrelation

10 Am meisten positiv korreliert

10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Taiko Pharmaceutical Korrelation - Währung/Rohstoff

-0.63
( weak negative )

-0.28
( neutral )

0.08
( neutral )

-0.46
( neutral )

0.11
( neutral )

0.32
( neutral )

Taiko Pharmaceutical Finanzdaten

Annual	2022
Umsatz:	¥5.04B
Bruttogewinn:	¥1.08B (21.41 %)
EPS:	¥-112.24

FY	2022
Umsatz:	¥5.04B
Bruttogewinn:	¥1.08B (21.41 %)
EPS:	¥-112.24

FY	2021
Umsatz:	¥10.72B
Bruttogewinn:	¥2.75B (25.63 %)
EPS:	¥-91.46

FY	2020
Umsatz:	¥17.68B
Bruttogewinn:	¥12.42B (70.24 %)
EPS:	¥89.18

Financial Reports:

No articles found.

Taiko Pharmaceutical Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)

Taiko Pharmaceutical Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 0.484 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Information

First Dividend	¥0.556	2009-03-26
Last Dividend	¥13.00	2021-12-29
Next Dividend	¥0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	18	--
Total Paid Out	¥72.22	--
Avg. Dividend % Per Year	0.00%	--
Score	1.18	--
Div. Sustainability Score	0.484
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2025-02-18)

¥0 Estimate 0.00 %

Dividend Stability

0.06 Very Bad

Dividend Score

1.18

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for JPX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
8365.T	Ex Dividend Junior	2023-09-28	Semi-Annually	0.00%
7745.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
6927.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
6289.T	Ex Dividend Knight	2023-08-30	Semi-Annually	0.00%
5011.T	Ex Dividend Junior	2023-09-28	Annually	0.00%
4212.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
3420.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
2502.T	Ex Dividend Knight	2023-12-28	Semi-Annually	0.00%
9436.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
8089.T	Ex Dividend Junior	2023-09-28	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.375	1.500	-7.50	-10.00	[0 - 0.5]
returnOnAssetsTTM	-0.144	1.200	-4.80	-5.76	[0 - 0.3]
returnOnEquityTTM	-0.261	1.500	-4.01	-6.02	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	3.19	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	2.54	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	1.719	1.500	1.560	2.34	[0.2 - 2]
debtRatioTTM	0.188	-1.500	6.86	-10.00	[0 - 0.6]
interestCoverageTTM	-85.89	1.000	-10.00	-10.00	[3 - 30]
operatingCashFlowPerShareTTM	0	2.00	0	0	[0 - 30]
freeCashFlowPerShareTTM	0	2.00	0	0	[0 - 20]
debtEquityRatioTTM	0.305	-1.500	8.78	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.394	1.000	6.76	6.76	[0.2 - 0.8]
operatingProfitMarginTTM	-0.127	1.000	-4.55	-4.55	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0.384	0.800	-0.775	-0.620	[0.5 - 2]
Total Score				0.484

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-6.82	1.000	-0.790	0	[1 - 100]
returnOnEquityTTM	-0.261	2.50	-2.58	-6.02	[0.1 - 1.5]
freeCashFlowPerShareTTM	0	2.00	0	0	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0	2.00	0	0	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.124	1.500	-4.16	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0	1.000	-2.50	0	[0.1 - 0.5]
Total Score				-1.598

Taiko Pharmaceutical

Taiko Pharmaceutical Co.,Ltd. engages in pharmaceuticals, infection control, and other businesses. The company manufactures and sells non-prescription drugs under the Seirogan and Seirogan Toi-A brands for the treatment of loose stools, diarrhea, food and water poisoning, vomiting, and related conditions; tablets for diarrhea; and quasi-drugs, such as Trumpet Intestinal Regulator BF. It also manufactures and sells sanitation control products under the Cleverin brand name to wholesalers, as well as Cleverin generator, a machine that emits low concentrations of chlorine dioxide gas; and supplies products using the patented Cleverin technology through OEM agreements and products developed jointly with other companies. It exports its products to the United States, Canada, Thailand, Vietnam, Malaysia, and Mongolia. Taiko Pharmaceutical Co.,Ltd. was incorporated in 1946 and is headquartered in Osaka, Japan.`